Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc.

9.61
EUR
+0.27
(+2.89%)
-0.54EPS
1.10BMarket Cap
Oct 29Next Earn

Income Statement (USD)

2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
- -
14
37
57
49
49
44
39
33
23
28
43
+ Selling, General & Admin
- -
2
8
10
11
11
12
10
8
7
8
9
+ Research & Development
- -
11
29
46
39
38
32
29
24
17
19
34
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-14
-37
-57
-49
-49
-44
-39
-33
-23
-28
-43
- Non-Operating (Income) Loss
- -
18
-1
-1
-2
-2
-38
5
9
4
35
-28
+ Interest Expense, Net
- -
- -
-1
-1
-2
-2
-1
- -
-1
-2
-2
-3
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
1
1
2
2
1
- -
1
2
2
3
+ Other Non-Op (Income) Loss
- -
18
- -
- -
- -
- -
-37
5
9
5
37
-25
Pretax Income
- -
-31
-36
-56
-47
-47
-6
-43
-41
-27
-62
-15
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-31
-36
-56
-47
-47
-6
-43
-41
-27
-62
-15
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-31
-36
-56
-47
-47
-6
-43
-41
-27
-62
-15
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-31
-36
-56
-47
-47
-6
-43
-41
-27
-62
-15
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-31
-36
-56
-47
-47
-6
-43
-41
-27
-62
-15
EBIT
- -
-14
-37
-57
-49
-49
-44
-39
-33
-23
-28
-43
EBITDA
- -
-14
-36
-56
-48
-48
-43
-38
-32
-23
-27
-43
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
- -
-14
-37
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
1
1
1
1
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
21
20
15
20
28
29
29
42
47
48
61
79
Basic EPS, GAAP
- -
-1.54
-2.36
-2.72
-1.71
-1.59
-0.2
-1.03
-0.89
-0.56
-1.02
-0.19
Basic EPS from Cont Ops
- -
-1.54
-2.36
-2.72
-1.71
-1.59
-0.2
-1.03
-0.89
-0.56
-1.02
-0.19
Diluted Weighted Avg Shares
21
20
15
20
28
29
29
42
47
48
61
80
Diluted EPS, GAAP
- -
-1.54
-2.36
-2.72
-1.71
-1.59
-0.2
-1.03
-0.89
-0.56
-1.02
-0.19
Diluted EPS from Cont Ops
- -
-1.54
-2.36
-2.72
-1.71
-1.59
-0.2
-1.03
-0.89
-0.56
-1.02
-0.19

Balance Sheet (USD)

2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
13
96
136
91
116
79
45
71
44
28
54
58
+ Cash, Cash Equivalents & STI
13
94
135
90
115
78
44
69
42
27
52
57
+ Cash & Cash Equivalents
13
4
5
45
39
5
16
63
13
13
9
5
+ ST Investments
- -
90
130
45
75
73
28
6
29
15
43
52
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
1
1
1
1
1
1
1
1
2
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
3
4
4
3
4
40
38
25
18
15
13
+ Property, Plant & Equip, Net
- -
2
3
3
2
4
3
4
3
1
1
1
+ Property, Plant & Equip
- -
2
4
4
5
7
6
8
7
6
6
4
- Accumulated Depreciation
- -
- -
1
2
2
3
4
4
5
5
5
3
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
37
34
22
16
13
11
+ LT Investments
- -
- -
- -
- -
- -
- -
37
34
22
16
13
11
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
1
1
- -
1
- -
- -
- -
- -
1
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
1
1
- -
1
- -
- -
- -
- -
1
1
Total Assets
13
98
140
95
118
84
86
109
68
46
69
71
+ Payables & Accruals
- -
3
5
8
6
8
9
7
8
5
5
8
+ Accounts Payable
- -
2
2
3
2
2
3
2
2
2
3
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
3
5
4
5
5
5
6
3
3
6
+ ST Debt
3
- -
- -
- -
- -
1
1
1
1
1
- -
- -
+ ST Borrowings
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
1
1
1
1
1
- -
- -
+ Other ST Liabilities
- -
1
1
1
1
2
2
2
1
1
30
1
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
1
1
1
2
2
2
1
1
30
1
Total Current Liabilities
3
3
6
9
7
10
12
10
11
7
35
9
+ LT Debt
- -
- -
- -
- -
- -
2
1
3
1
- -
1
1
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
2
1
3
1
- -
1
1
+ Other LT Liabilities
10
126
1
1
1
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
10
126
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
10
126
1
1
1
2
1
3
1
- -
1
1
Total Liabilities
13
130
7
10
8
13
13
12
12
7
36
10
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
201
208
281
288
295
362
364
374
431
474
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
201
208
281
288
295
362
364
374
431
474
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
-31
-68
-124
-170
-217
-223
-266
-308
-335
-397
-412
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
2
-1
-1
-1
-1
Equity Before Minority Interest
- -
-31
133
85
110
71
72
97
56
39
33
61
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
-31
133
85
110
71
72
97
56
39
33
61
Total Liabilities & Equity
13
98
140
95
118
84
86
109
68
46
69
71
Shares Outstanding
20
20
21
21
29
28
28
47
47
49
68
75
Number of Employees
28
33
44
55
49
53
42
28
29
28
31
37
Capital Leases - Total
- -
- -
- -
- -
- -
3
2
4
3
1
1
1
Net Debt
-10
-4
-5
-45
-39
-5
-16
-63
-13
-13
-9
-5
Net Debt to Equity
6,237.11
13.2
-3.8
-53.17
-35.52
-7.25
-22.81
-65.31
-23.45
-32.62
-26.84
-7.48
Tangible Common Equity Ratio
-1.27
-31.59
94.76
89.51
93.32
85.01
84.36
88.77
82.23
84.92
47.26
86.06
Current Ratio
4.69
31.16
22.89
10.17
16.45
7.76
3.73
7.36
4.06
4.07
1.54
6.21
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
- -
-31
-36
-56
-47
-47
-6
-43
-41
-27
-62
-15
+ Depreciation & Amortization
- -
- -
1
1
1
1
1
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
18
4
6
7
7
-31
9
13
7
38
-21
+ Stock-Based Compensation
- -
- -
4
6
7
7
6
4
3
2
3
5
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
18
1
- -
-1
-1
-37
5
10
4
35
-27
+ Chg in Non-Cash Work Cap
- -
2
3
3
-1
2
2
-3
1
-4
-2
4
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
-1
- -
1
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
- -
- -
- -
- -
- -
1
- -
-2
1
+ Inc (Dec) in Accts Payable
- -
2
3
3
-2
2
2
-2
1
-4
1
3
+ Inc (Dec) in Other
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-11
-28
-46
-41
-37
-35
-37
-27
-24
-25
-33
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-2
-2
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
-2
-2
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
71
1
65
- -
1
61
- -
8
16
- -
+ Increase in Capital Stock
- -
- -
71
1
65
- -
1
61
- -
8
16
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-90
-40
85
-30
3
45
22
-23
16
-27
-8
+ Dec in LT Investment
- -
14
218
173
132
142
87
31
43
63
43
84
+ Inc in LT Investment
- -
-104
-258
-88
-162
-139
-43
-9
-66
-47
-70
-92
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-92
-43
85
-30
3
45
22
-23
16
-27
-8
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
95
- -
1
- -
- -
- -
1
- -
- -
33
36
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
95
71
1
65
- -
1
62
- -
8
49
36
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
-8
1
40
-6
-34
11
47
-50
-1
-4
-4
EBITDA
- -
-14
-36
-56
-48
-48
-43
-38
-32
-23
-27
-43
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
- -
-13
-30
-46
-41
-37
-35
-37
-27
-24
-25
-33
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-13
-30
-46
-41
-37
-35
-37
-27
-24
-25
-33
Free Cash Flow per Basic Share
- -
-0.64
-1.95
-2.27
-1.5
-1.27
-1.18
-0.88
-0.59
-0.5
-0.42
-0.42
Price/Free Cash Flow
- -
- -
- -
- -
- -
- -
-3.2
-2.69
-1.35
-3.43
-12.36
-17.76
Cash Flow to Net Income
- -
0.36
0.77
0.83
0.87
0.8
5.8
0.85
0.65
0.89
0.41
2.15
Capital Expenditures
- -
-2
-2
- -
- -
- -
- -
- -
- -
- -
- -
- -